MerLion Pharmaceuticals Pte. Ltd. gained two new antibiotics that are about to enter the clinic, plus a platform for identifying novel anti-virulence molecules through its stock-based acquisition of Combinature Biopharm AG and Athelas SA. (BioWorld Today)
MerLion Pharmaceuticals Pte. Ltd. gained two new antibiotics that are about to enter the clinic, plus a platform for identifying novel anti-virulence molecules through its stock-based acquisition of Combinature Biopharm AG and Athelas SA. (BioWorld Today)
Shares in Pharmexa A/S fell 25 percent on the Copenhagen Stock Exchange Monday on news that the company decided to discontinue recruitment onto a Phase II trial of a therapeutic vaccine for metastatic breast cancer. (BioWorld International)
Shares in Pharmexa A/S fell 25 percent on the Copenhagen Stock Exchange Monday on news that the company decided to discontinue recruitment onto a Phase II trial of a therapeutic vaccine for metastatic breast cancer. (BioWorld International)
Paion AG is accelerating the Phase III development program for its lead compound, the recombinant plasminogen activator Desmoteplase, which is in development for treating acute ischemic stroke. (BioWorld International)
